Allied Market Research analyzes that the global biosimilars industry was estimated at $15.9 billion in 2021, and is anticipated to hit $143.6 billion by 2031, registering a CAGR of 24.7% from 2022 to 2031. Request Sample Copy of Report: https://www.alliedmarketresearch.com/request-sample/162 The biosimilars market is a growing industry that includes companies that develop, manufacture, and sell these drugs. The market is driven …